FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity
BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration (FDA) has officially closed its inspection of a single ...
BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration (FDA) has officially closed its inspection of a single ...
Dell Technologies saw its shares decline on Friday following a weaker-than-expected revenue outlook, but analysts suggest the dip could be ...
Data Center Growth and AI Innovation Drive Strong Q4 and Full-Year Performance NVIDIA (NVDA) continues its meteoric rise, reporting record-breaking ...
Automaker responds to investor demands with accelerated share repurchase program General Motors (GM) is delivering for its shareholders, announcing a ...
Record Revenue Growth and Expansion Signal Promising 2025 Outlook Perfect Corp (PERF), a global leader in AI and AR SaaS ...
Mediterranean Fast-Casual Chain Achieves 35.1% Revenue Growth and Expands Footprint CAVA Group (CAVA) delivered another year of impressive growth in ...
Investor Confidence Wanes Amid Trump’s Trade Policies and Industry Setbacks Bitcoin (BTC.X) fell below $90,000 on Tuesday, marking its lowest ...
Meme-Stock Frenzy Collides with Regulatory Uncertainty and Investor Skepticism Hims & Hers Health (HIMS) is at a crossroads as it ...
Regulatory Easing Under Trump Boosts Crypto Industry Confidence Robinhood (HOOD) announced that the U.S. Securities and Exchange Commission (SEC) has ...
CEO Brian Niccol Restructures Leadership as Company Struggles with Declining Sales Starbucks (SBUX) is set to eliminate 1,100 corporate support ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?